DALLIA NSOESIE: Open Payments
NPI 1154814762 · NOTTINGHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 38 payments from 12 companies in 2025. Trend: 2023 $967 · 2024 $1,143 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $201 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $74 |
| Abbott Laboratories | 3 | $66 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Globus Medical, Inc. | 2 | $53 |
| ABBVIE INC. | 3 | $53 |
| Averitas Pharma Inc. | 2 | $50 |
| Tonix Medicines, Inc. | 1 | $21 |
| Electronic Waveform Lab, Inc. | 2 | $20 |
| Axsome Therapeutics, Inc. | 1 | $20 |
Products named: RELISTOR, JOURNAVX, ETERNA, Belbuca, QUTENZA, QULIPTA, Senza, VYRSA V1.
Industry payments across MD — which companies pay providers there.
